chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Slight sore arm; slight headache; some GI issues; generally don't feel good; unusual bowel movements; chills; feels like a fever, but no fever; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administration date 22Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "Slight sore arm"; HEADACHE (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "slight headache"; GASTROINTESTINAL DISORDER (non-serious) with onset Mar2021, outcome "unknown", described as "some GI issues"; FEELING ABNORMAL (non-serious) with onset Mar2021, outcome "unknown", described as "generally don't feel good"; BOWEL MOVEMENT IRREGULARITY (non-serious) with onset Mar2021, outcome "unknown", described as "unusual bowel movements"; CHILLS (non-serious) with onset Mar2021, outcome "unknown", described as "chills"; PYREXIA (non-serious) with onset Mar2021, outcome "unknown", described as "feels like a fever, but no fever". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient received her second dose of the Pfizer-BioNTech Covid19 vaccine on 22Mar2021. She states that had a slight sore arm and a slight headache for a short time afterword, then she felt fine. Then as the week went on, she started with some GI issues, generally don't feel good, unusual bowel movements, chills, feels like a fever, but no fever. She stated that she kept on thinking she had a fever, and she took her temperature and she don't have a fever. She just wanted to know if this is all normal.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Started with headaches for a couple of days, then went to terrible flu like pains in my back.  I was treated for an infecton with an antibiotic and motrin, because my white blood count was down to 1.7.  After that the back pain got better, but I noticed that the toothpaste burnt my mouth at night when I brushed my teeth. The next morning my tognue was sore and then my tongue swelled up and I had a lot of sores in my mouth and couldn't eat for several days.
No additional AE reported; the vaccine was administered after expiration; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/ allergies were not reported.   On 11-MAY-2021, the patient was administered with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II) after expiration (0.5 ml, rHA, lot # S014431, expiration date 09-MAY-2021; anatomical location, strength and route were not reported) for prophylaxis (expired vaccine used). No additional adverse events was reported.
Febrile seizure (temp 104.9), arms and legs were shaking and eyes were rolling back for 45 seconds. he was confused, crying and fussy afterward.
Chills; mild fever; Very very very bad muscle aches; pains; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 50-year-old female patient received BNT162b2 (BNT162B2), on 08Jun2022 at 09:45 as dose 4 (booster), single (Lot number: FL3197, Expiration Date: 30Jun2022) at the age of 50 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose 3, Single, LOT: FH8027), administration date: 09Dec2021, when the patient was 50-year-old, for covid-19 immunization; BNT162b2 (Dose 2, Single, LOT: EP6955), administration date: 30Mar2021, when the patient was 49-year-old, for covid-19 immunization; BNT162b2 (Dose 1, Single, LOT: EL3247 (handwriting is hard to read)), administration date: 09Mar2021, when the patient was 49-year-old, for covid-19 immunization; Flu shot, administration date: Oct2021, reaction(s): "sore arm".  The following information was reported: CHILLS (non-serious) with onset 08Jun2022, outcome "recovered" (Jun2022); MYALGIA (non-serious) with onset 08Jun2022, outcome "recovered" (Jun2022), described as "Very very very bad muscle aches"; PYREXIA (non-serious) with onset 08Jun2022, outcome "recovered" (Jun2022), described as "mild fever"; PAIN (non-serious) with onset 08Jun2022, outcome "recovered" (2022), described as "pains".  Additional information: No additional vaccines administered on Same Date of the Pfizer Suspect and no prior vaccinations (within 4 weeks). No emergency room visit, and physician office visit required for AEs. The patient stated that she did not feel great, but it wasn't that bad. After second booster shot about 0945 yesterday morning. Late last evening, started feeling chills, mild fever, very very very bad muscle aches and pains that persisted throughout the course of the evening.All symptoms have completely resolved.
Tingling in one of her fingers, paresthesias like feeling. It started couple of hours after immunization on 5/2/2018. She already visited her Dr and Dr told her to just watch if for week. I follow up with her today, according to her she is not having any tingling in finger right now.
I was very cold for about 6 hours - same day - arm very sore - red - swollen for a week.
One hour after vaccine received I developed severe abdominal pain and back pain . The next day around 10 I started to projectile vomit . Today , aug 12 I developed severe shakiness , hear racing , headache nausea and severe Lethargy . Difficult to ambulate due to weakness and almost an out of body experience . Got seen in clinic and my heart rate and blood pressure were elevated . I got sent home from work and almost fell asleep at wheel . When I got home I slept for hours and I was very nauseous . Now I keep throwing up bile  and developed hives on my chest which the hives subsided . I have still a lot of lethargy and don?t feel right . Severe headache and back pain . When I went to clinic the nursing assistant said the nurse practitioner wants to see me because she thinks it is reaction to vaccine but unfortunately they were 2 hours behind . I called employee health , I work in hospital , and they immediately sent me home . I was never able to get evaluated by nurse or doctor . I?ve been trying to get hold of my pcp but there has been no call back at this time
My motor tics got worse and more noticeable by clients of mine. I have minor Tourette?s. They are still worse and I?m hoping the side effects subside
pt recv vax 19JAN96 & on 20JAN96 pt devel a fever of 101 & exp gen aches & tightness in neck & throat w/no major distress;f/u correspondence indicated pt had mononucleosis & that is was felt exp was not r/t vax;
I started to have this muscle pain in my left arm and gradually started going up my shoulder than down to my right arm, it aches a lot. they took X-ray and could figure out why that was happening. I went to a physician was also not sure but he game me a steroid that didn't really help. I still don't know what's going on.
7PM fever 104 lasted 8 to 9 hrs; had been pre-tx w/APAP a/immun & they every 4 hrs x 3 days; dx ear infect started on suprax;
Awoke with extreme pain in vaccination arm and was unable to move it independently. When rising to obtain Tylenol, broke out into a cold sweat, sudden onset of significant nausea and dizziness. I was unable to remain erect. Symptoms did subsided when prone. Unable to get up without nausea and dizziness for approximately 5 hours. Following day, headache and fatigue throughout the day. Arm remained painful when engaging muscle for several days. Minimal discomfort in arm at 8 days post vaccination.
This case was received on 29 March 2012 from Health Care Professional under reference number 12-0207. 4 patients with no reported age, gender, medical history and concomitant medication received a dose of PENTACEL (batch number C3928AA), FLUZONE (batch number: UT4114BA), ROTATEQ (batch number: various lots) and Pneumococcal Vaccine (batch number: F24141) route and site of administration not reported on an unspecified date. It was reported that one of the patients (which one not specified) had Flu when he/she was vaccinated with FLUZONE. On an unspecified date hours after vaccination the patients were presented with Fever, Excessive Crying and Vomiting. Lab data and corrective treatment were not reported. The outcome of the events was reported as unknown. This is a cluster case as it was reported by same HCP for 4 patients. Follow-up information was received on 22 May 2012 from a healthcare professional. The reporter for this case is the same as for non-serious cases: 2012-05376 and 2012-05377. Information regarding the other patient (who was hospitalized) is captured in serious case number 2012-04126. A six-month-old female patient received a left thigh intramuscular injection of PENTACEL, sanofi pasteur Ltd., lot number C4059AA (previously reported as C3928AA); a left thigh intramuscular injection of FLUZONE, sanofi pasteur Inc., lot number UT4114BA; a right thigh intramuscular injection of PREVNAR 13, Wyeth, lot number F24141 and an oral dose of ROTATEQ, Merck, lot number 05438A on 20 March 2012. The next day on 21 March 2012, the patient developed a hard bump at injection site on right upper leg; and raised bumps on the upper left thigh. The patient had an office visit for rash on 21 March 2012. No laboratory or diagnostic tests were reported. No treatments were reported. The patient's past medical history or concomitant medications were not reported. The patient recovered, symptoms resolved on 05 April 2012. Documents held by sender: None. Follow-up information received on 11 June 2012: The lot number of the PENTACEL was C4059AA; the dose was 3rd in the series. The FLUZONE dose was 1st in the series. The ROTATEQ dose was 3rd in the series. The PREVNAR dose was 3rd in the series. The adverse event fever, persistent crying and vomiting no longer reported. The patient have no known allergy and patient not received any other vaccines prior 4 weeks.
Pt developed hives/itching - face, neck and forearms. As of 11/10/08 pt has itching of forearms only.
p/vax pt exp localized lt arm pain @ the inj site & pain on lt side from buttock to knee;
rt arm became warm & swollen by late afternoon entire arm from elbow to shoulder swollen;became discolored-1wk later knot the size of an orange  @ inj site;
first dose / on January 27, 2021 /second dose / administered on February 26, 2021.; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 59-year-old male patient who received Herpes zoster (Shingrix) (batch number 3K743, expiry date 7th November 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 26th February 2021, the patient received the 2nd dose of Shingrix. On 26th February 2021, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional information was provided as follows:  The age at vaccination was not reported. The patient received 1st dose on 27 January 2021( batch number BA5GK, expiry date 4 November 2022). The medical assistant reported that  the patient received 2nd dose of Shingrix, less than the recommended interval, which led to shortening of vaccination schedule.  The patient received 2nd dose 30 days after 1st dose. The reporter consented to follow up.
Patient presents to ED with left hand swelling, fever, and left arm pain on 3/10/21 after receiving his COVID 19 vaccine at Clinic on 3/4/21. I'm unable to determine the route of administration from the immunization documentation. Patient reports that the swelling significantly increased over the past day with increased swelling in his left hand and pain from his left clavicle to his left hand. Patient is febrile upon presentation with a documented temperature of 38.7 and sinus tachycardia. EKG is otherwise unremarkable. Patient has been diagnosed with left arm cellulitis and is being admitted to our hospital. He has been started on vancomycin 800 mg and Zosyn 3.375 g IV.
This spontaneous report as received from a medical assistant refers to a 18 month old patient of unknown gender. The concurrent conditions, drug reactions/allergies and medical history of the patient were not reported. On 14-NOV-2016, the patient was vaccinated with an improperly stored dose of VARIVAX (strength, dose, route of administration, anatomical location, lot number and expiration date were unknown) for prophylaxis. On the same date, the patient was vaccinated with an improperly stored dose of MMRII (strength, dose, route of administration, anatomical location, lot number and expiration date were unknown) for the same indication. Both vaccines were stored at 1.1 Celsius degrees (°C) for 27 minutes, 0.7 °C for 19 minutes, 1.1 °C for 36 minutes, 0.7 °C for 29 minutes, 1.3 °C for 17 minutes, 1.1 °C for 20 minutes, 0.9 °C for 26 minutes, 0.7 °C for 31 minutes and 1.2 °C for 24 minutes. There was no previous temperature excursion. Moreover, the temperature excursions were detected by a data logger. No concomitant therapies nor adverse effects were reported. No product quality complaint was involved.  This is one of several cases from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA007921: US-009507513-1701USA004148: US-009507513-1701USA003168: US-009507513-1701USA007912: US-009507513-1701USA007922: US-009507513-1701USA007881: US-009507513-1701USA007913: US-009507513-1701USA007882: US-009507513-1701USA004150: US-009507513-1701USA007958: US-009507513-1701USA007906: US-009507513-1701USA007895: US-009507513-1701USA007896: US-009507513-1701USA007923: US-009507513-1701USA004152: US-009507513-1701USA007883: US-009507513-1701USA007897: US-009507513-1701USA007905: US-009507513-1701USA007884: US-009507513-1701USA007924: US-009507513-1701USA007925: US-009507513-1701USA007847: US-009507513-1701USA007885: US-009507513-1701USA007908: US-009507513-1701USA007909: US-009507513-1701USA007898: US-009507513-1701USA007914: US-009507513-1701USA007915: US-009507513-1701USA007916: US-009507513-1701USA007848: US-009507513-1701USA007849:
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 19-DEC-2016, the patient was vaccinated with a dose of ZOSTAVAX lot # M035146, expiration date 26-JUL-2016, for prophylaxis (dose, route and anatomical administration were not reported) following a temperature excursion of between 10.7 F and 30 F (-11.8 and -1.1 Celsius), exact details unknown, for 14 hours. No adverse effects were reported in the patient. Additional information has been requested.
Shortly after receiving the vaccine the patient fainted and bumped his head from the fall. He was very pale, clammy, hot and somewhat disoriented from the reaction. After some water, food, and sitting patient recovered almost fully.  He does report having similar reactions to other vaccines/blood draws. He was checked on by phone that same night and about 36 hours later and overall was doing ok.
Pt arrived today to receive her 2nd Pfizer vaccine. Pt approached my desk and informed me she did not have her vaccine card. She requested a new Covid-19 vaccination record card. I confirmed her full name and DOB via System and I noticed two vaccines documented in System, one from 7/14/21(Pfizer) and one for today. I wanted to confirm that I filled out her card correctly therefore I signed into Database and noticed the pt receive the J&J vaccine on 3/12 and Pfizer on 7/14/21. I asked the pt if she ever received the J&J vaccine and she answered with "no". I then checked Database again to confirm the right pt, DOB, address and asked the pt again if she received any vaccine besides the Pfizer one and she said "no". I explained to the pt that our records show she received the J&J vaccine on 3/12/21. I explained to her that there is not enough information/adverse effects with taking J&J and Pfizer together and she should not have received the Pfizer vaccine. I informed the pt that we may not be able to give her the 2nd pfizer due to this guideline. I informed her I would check with my charge nurse who confirmed that the pt should not receive the 2nd Pfizer vaccine. Pt appeared upset and left stating "now I am not fully vaccinated".   Pt then returned about 20 minutes later and approached a different nurse to receive her 2nd Pfizer vaccine. Per nurse the pt stated she is here to receive her 2nd vaccine and did not have her vaccine card. The charge nurse was notified and walked over to the pt and nurse to  inform her the pt was already here to receive her pfizer vaccine but we couldn't due to her receiving the J&J vaccine already The pt then stated she was here just to receive her vaccine card. The nurse completed her vaccine card, which included the J&J and Pfizer vaccine information.
pt felt lightheaded and was laid supine on the floor. pt was given gatorade and granola bars feel were elevated. examined by onsite medical doctor and onsite rns and ems. Pt vitals  were hr 67   o2 sat of99% bp 130/74 resp 14. pt observed for 30 mins and sent home in care of family
On Day 9 (1-23-21) post Moderna Vaccine I developed red raised rash at injection site. I applied Hydrocortisone lotion and it was gone the next day (1-24-21). At midnight on 1-25-21 (day 10 post vaccine) I woke up to extremely severe neck pain, knee joint pain and pain in my hands, specially thumb joints. Pain was so severe I started throwing up, vomiting x 20 minutes. Shakes ands tremors started. I took Tramadol for the pain at 2 am. Nausea continued,  finally at 3 am I was able to dose with heating pad under my neck. At 7 am my husband was able to get Benadryl 50 mg which I took along with Tylenol 2 tabs. I was able to dose until noon on 1-24-21, the pain had subsided but my joints were still very sore.
Injury; Inability to vocalize; Immediate regression/some behavioral changes; This is a spontaneous report from a contactable consumer (patient's parent). A male patient of an unspecified age received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, Lot number and expiration date were not reported), with route of administration and therapy date unspecified, at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had an injury; had inability to vocalize; and immediate regression/some behavioral changes. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Extreme sensitivity to touch and light. Complete loss of speech. Self harming behavior. Child is now autistic.
2"x3" area of solid red raised, blistery skin. Tender to touch.
unconscious; fell down and hit bench; pain behind the neck/tried to move neck around in any direction, it would hurt; pain when moving the leg; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the parent.  A 17-year-old male patient received BNT162b2 (BNT162B2), on 16Jan2022 at 09:00 as dose 3 (booster), single (Lot number: F51614) at the age of 17 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (1st dose, Lot EW973 or 0173, expiration is unknown, injected in left arm), administration date: 17May2021, when the patient was 17-year-old, for COVID-19 Immunization; BNT162b2 (2nd dose, Lot EW0196, injected in left arm, expiration is unknown), administration date: 21Jun2021, when the patient was 17-year-old, for COVID-19 Immunization. The following information was reported: FALL (non-serious) with onset 16Jan2022, outcome "recovered" (2022), described as "fell down and hit bench"; NECK PAIN (non-serious) with onset 16Jan2022, outcome "not recovered", described as "pain behind the neck/tried to move neck around in any direction, it would hurt"; LOSS OF CONSCIOUSNESS (medically significant) with onset 16Jan2022, outcome "unknown", described as "unconscious"; PAIN (non-serious) with onset 2022, outcome "unknown", described as "pain when moving the leg". The events "unconscious", "fell down and hit bench", "pain behind the neck/tried to move neck around in any direction, it would hurt" and "pain when moving the leg" required physician office visit and emergency room visit. Clinical course: The consumer's son received booster dose of the Pfizer COVID 19 vaccine on 16Jan2022, from Pharmacy and after his son received it, he fell down and hit bench. It was behind the cabinet and his son was brought to the hospital; however, insurance only covered half of the hospital bill. He thought would cover it and they would not. They called the ambulance, and he was taken to the hospital where he spent 2 1/2 hours and was released. When he hit bench, he got pain behind the neck. After a while, he was feeling better, and the muscle was better. At this moment he did not have any lasting effects. Around 1 month, pain when moving the leg. His son came on the line and clarified. He was not sure what happened, he was unconscious. When he tried to move neck around in any direction, it would hurt. Around 1 month after, he was still having pain in the neck not the leg. AE(s) require a visit to Emergency Room. They called ambulance 911 and the ambulance came. He did not know what medical treatment was offered, but he just had the hospital bill. AE(s) require a visit to Physician Office. After 1 month, went to family physician. No treatment offered. At the time, he said he was ok. The patient was not hospitalized. No family Medical History Relevant to AE(s).
This case was reported by a physician via sales rep and described the occurrence of swelling in a elderly female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced swelling and feeling bad. On an unknown date, the outcome of the swelling and feeling bad were unknown. It was unknown if the reporter considered the swelling and feeling bad to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient felt swelling all over their body and felt bad. The reporter agreed to be followed up.
facial swelling/cheek swelling; lip swelling; This is a spontaneous report from a contactable other hcp . A 64-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Two days after the first dose of the Pfizer covid-19 vaccine, the patient experienced facial, lip swelling and cheek swelling. There was not anything serious like tongue and throat swelling. The patient's reaction was not serious and resolved after treatment with Benadryl. The patient was asking if patient get the second dose of the Pfizer covid-19 vaccine. Therapeutic measures were taken as a result of events with Benadryl. The outcome of events were recovered on an unspecified date.  No follow-up attempts are needed. Information about lot/batch number cannot be requested. No further information is expected.